{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T18:28:08Z","timestamp":1771698488052,"version":"3.50.1"},"reference-count":16,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,4,29]],"date-time":"2009-04-29T00:00:00Z","timestamp":1240963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Gastric acid control is important for treatment of gastro\u2010oesophageal reflux disease associated with Barrett\u2019s oesophagus. Substantial indirect evidence suggests that gastric acid control may have a chemopreventive role in Barrett\u2019s oesophagus.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To compare the pharmacodynamic efficacy of esomeprazole and lansoprazole at two dosages for intragastric pH control with Barrett\u2019s oesophagus.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Patients with Barrett\u2019s oesophagus received open\u2010label consecutive treatment (a 15\u2010day period of once\u2010daily dosing followed by a 10\u2010day period of twice\u2010daily dosing) with esomeprazole (40\u2010mg capsules) and lansoprazole (30\u2010mg capsules) in random order with no washouts. Twenty\u2010four\u2010hour intragastric pH was recorded on the last day of each dosing period. The primary end point was the percentage of time with intragastric pH\u2003&gt;\u20034.0.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> In the per\u2010protocol once\u2010 (<jats:italic>n\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>46) and twice\u2010daily (<jats:italic>n\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>41) analyses, the percentage of time with intragastric pH\u2003&gt;\u20034.0 was significantly (<jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0.0001) longer after once\u2010 (67.1%) or twice\u2010daily (81.2%) esomeprazole than after once\u2010 (50.8%) or twice\u2010daily (64.3%) lansoprazole. The proportion of patients with intragastric pH\u2003&gt;\u20034.0 for &gt;12\u2003h was significantly higher for esomeprazole than lansoprazole with once\u2010 (<jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0.004) and twice\u2010daily (<jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0.016) dosing.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Esomeprazole 40\u2003mg is significantly more effective than lansoprazole 30\u2003mg in controlling intragastric pH with Barrett\u2019s oesophagus.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2009.04032.x","type":"journal-article","created":{"date-parts":[[2009,4,30]],"date-time":"2009-04-30T02:40:57Z","timestamp":1241059257000},"page":"138-145","source":"Crossref","is-referenced-by-count":14,"title":["Clinical trial: intragastric acid control in patients who have Barrett\u2019s oesophagus\u2014comparison of once\u2010 and twice\u2010daily regimens of esomeprazole and lansoprazole"],"prefix":"10.1111","volume":"30","author":[{"given":"S. J.","family":"SPECHLER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. N.","family":"BARKER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. G.","family":"SILBERG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,6,26]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00939.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp012118"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.06.061"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119018"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70254-X"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.30993"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1999.0029900327"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655200453557"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30228.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2004.tb05991.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00661.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2050.2003.00327.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02534.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.042143"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.01835.x"},{"key":"e_1_2_6_17_2","unstructured":"US National Institutes of Health Clinical Trials Registry.NCT00357682. Esomeprazole with or without aspirin in preventing oesophageal cancer in patients with Barrett\u2019s metaplasia.http:\/\/www.clinicaltrials.gov\/ct2\/results?term=NCT00357682. Accessed January 12 2009."}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2009.04032.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2009.04032.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:09:13Z","timestamp":1697227753000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2009.04032.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,26]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1365-2036.2009.04032.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04032.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,26]]}}}